Recommendations from our site
“It is about Ozempic—the product which was Novo Nordisk’s patented weight loss drug—but it’s not just about that; it’s also about the entire cultural and pharmaceutical revolution that that set off. Ozempic was the initial discovery that got people looking into it, but it’s led to Wegovy, Mounjaro and others. It’s about the chemistry and the discovery of GLP-1 drugs, which is the generic name for them, and the scientists behind that. It also tells us about the ways in which Novo Nordisk’s own fortunes were affected by the discovery…The discovery has clearly made a huge cultural difference. It’s very hard to have a conversation these days without somebody pointing to the benefits, either for themselves or for unnamed others, of being able to use the weight loss drugs, and indeed some of the downsides, which have spilled over into everything from restaurant bookings to portion sizes. There is a sort of cultural history built into the book.” Read more...
The Best Business Books of 2026: the Financial Times Business Book of the Year Award
Andrew Hill, Journalist
Our most recommended books
-

A Random Walk Down Wall Street
by Burton Malkiel -

Common Sense on Mutual Funds
by John C. Bogle -

Cobalt Red: How the Blood of the Congo Powers Our Lives
by Siddharth Kara -

Booms and Depressions
by Irving Fisher -

The Economics of Inflation
by Constantino Bresciani Turroni -

A History of Interest Rates
by Richard Sylla & Sidney Homer






